PHKA2 and babesiosis: Currently, few studies report inhibitors targeting BdPyK I. Given the pivotal role of PyK in parasite metabolism and growth, the development of specific inhibitors against this enzyme is essential for the prevention and treatment of babesiosis caused by B. duncani.